Neurobiology of Aging
Volume 31, Issue 9 , Pages 1543-1553 , September 2010

Mevastatin accelerates loss of synaptic proteins and neurite degeneration in aging cortical neurons in a heme-independent manner

Received 13 March 2008 ,Revised 11 July 2008 ,Accepted 5 September 2008.

References 

  1. Asahi M, Huang Z, Thomas S, Yoshimura S, Sumii T, Mori T, et al. Protective effects of statins involving both eNOS and tPA in focal cerebral ischemia. J. Cereb. Blood Flow Metab. 2005;25:722–729
  2. Besshoh S, Chen S, Brown IR, Gurd JW. Developmental changes in the association of NMDA receptors with lipid rafts. J. Neurosci. Res. 2007;85:1876–1883
  3. Bitar M, Weiner M. Modification of age-induced changes in heme and hemoproteins by testosterone in male rats. Mech. Ageing Dev. 1983;23:285–296
  4. Bitar MS, Shapiro BH. Aberration of heme and hemoprotein in aged female rats. Mech. Ageing Dev. 1987;38:189–197
  5. Bosel J, Gandor F, Harms C, Synowitz M, Harms U, Djoufack PC, et al. Neuroprotective effects of atorvastatin against glutamate-induced excitotoxicity in primary cortical neurones. J. Neurochem. 2005;92:1386–1398
  6. Cerezo-Guisado MI, Garcia-Roman N, Garcia-Marin LJ, Alvarez-Barrientos A, Bragado MJ, Lorenzo MJ. Lovastatin inhibits the extracellular-signal-regulated kinase pathway in immortalized rat brain neuroblasts. Biochem. J. 2007;401:175–183
  7. Chernova T, Nicotera P, Smith AG. Heme deficiency is associated with senescence and causes suppression of N-methyl-D-aspartate receptor subunits expression in primary cortical neurons. Mol. Pharmacol. 2006;69:697–705
  8. Chernova T, Steinert JR, Guerin CJ, Nicotera P, Forsythe ID, Smith AG. Neurite degeneration induced by heme deficiency mediated via inhibition of NMDA receptor-dependent extracellular signal-regulated kinase 1/2 activation. J. Neurosci. 2007;27:8475–8485
  9. Davies R, Schuurman A, Barker CR, Clothier B, Chernova T, Higginson FM, et al. Hepatic gene expression in protoporphyic Fech mice is associated with cholestatic injury but not a marked depletion of the heme regulatory pool. Am. J. Pathol. 2005;166:1041–1053
  10. Follenzi A, Naldini L. HIV-based vectors. Preparation and use. Methods Mol. Med. 2002;69:259–274
  11. Grosser N, Erdmann K, Hemmerle A, Berndt G, Hinkelmann U, Smith G, et al. Rosuvastatin upregulates the antioxidant defense protein heme oxygenase-1. Biochem. Biophys. Res. Commun. 2004;325:871–876
  12. Grosser N, Hemmerle A, Berndt G, Erdmann K, Hinkelmann U, Schurger S, et al. The antioxidant defense protein heme oxygenase 1 is a novel target for statins in endothelial cells. Free Radic. Biol. Med. 2004;37:2064–2071
  13. Hering H, Lin CC, Sheng M. Lipid rafts in the maintenance of synapses, dendritic spines, and surface AMPA receptor stability. J. Neurosci. 2003;23:3262–3271
  14. Hirose W, Ikematsu K, Tsuda R. Age-associated increases in heme oxygenase-1 and ferritin immunoreactivity in the autopsied brain. Leg Med. (Tokyo). 2003;5(Suppl 1):S360–S366
  15. Hsieh CH, Rau CS, Hsieh MW, Chen YC, Jeng SF, Lu TH, et al. Simvastatin-Induced Heme Oxygenase-1 Increases Apoptosis of Neuro 2A Cells in Response to Glucose Deprivation. Toxicol. Sci. 2008;101:112–121
  16. Hsu M, Muchova L, Morioka I, Wong RJ, Schroder H, Stevenson DK. Tissue-specific effects of statins on the expression of heme oxygenase-1 in vivo. Biochem. Biophys. Res. Commun. 2006;343:738–744
  17. Johnson-Anuna LN, Eckert GP, Keller JH, Igbavboa U, Franke C, Fechner T, et al. Chronic administration of statins alters multiple gene expression patterns in mouse cerebral cortex. J. Pharmacol. Exp. Ther. 2005;312:786–793
  18. Koeppen AH, Dickson AC, Smith J. Heme oxygenase in experimental intracerebral hemorrhage: the benefit of tin-mesoporphyrin. J. Neuropathol. Exp. Neurol. 2004;63:587–597
  19. Kotti TJ, Ramirez DM, Pfeiffer BE, Huber KM, Russell DW. Brain cholesterol turnover required for geranylgeraniol production and learning in mice. Proc. Natl. Acad. Sci. U.S.A. 2006;103:3869–3874
  20. Kumar B, Andreatta C, Koustas WT, Cole WC, Edwards-Prasad J, Prasad KN. Mevastatin induces degeneration and decreases viability of cAMP-induced differentiated neuroblastoma cells in culture by inhibiting proteasome activity, and mevalonic acid lactone prevents these effects. J. Neurosci. Res. 2002;68:627–635
  21. Liao JK, Laufs U. Pleiotropic effects of statins. Annu. Rev. Pharmacol. Toxicol. 2005;45:89–118
  22. Mauch DH, Nagler K, Schumacher S, Goritz C, Muller EC, Otto A, et al. CNS synaptogenesis promoted by glia-derived cholesterol. Science. 2001;294:1354–1357
  23. Nilsson CL, Brinkmalm A, Minthon L, Blennow K, Ekman R. Processing of neuropeptide Y, galanin, and somatostatin in the cerebrospinal fluid of patients with Alzheimer’s disease and frontotemporal dementia. Peptides. 2001;22:2105–2112
  24. Paredes MF, Greenwood J, Baraban SC. Neuropeptide Y modulates a G protein-coupled inwardly rectifying potassium current in the mouse hippocampus. Neurosci. Lett. 2003;340:9–12
  25. Pavlov OV, Bobryshev YuV, Balabanov YuV, Ashwell K. An in vitro study of the effects of lovastatin on human fetal brain cells. Neurotoxicol. Teratol. 1995;17:31–39
  26. Pertusa M, Garcia-Matas S, Rodriguez-Farre E, Sanfeliu C, Cristofol R. Astrocytes aged in vitro show a decreased neuroprotective capacity. J. Neurochem. 2007;101:794–805
  27. Saavedra A, Baltazar G, Carvalho CM, Duarte EP. GDNF modulates HO-1 expression in substantia nigra postnatal cell cultures. Free Radic. Biol. Med. 2005;39:1611–1619
  28. Sangerman J, Killilea A, Chronister R, Pappolla M, Goodman SR. Alpha-spectrins are major ubiquitinated proteins in rat hippocampal neurons and components of ubiquitinated inclusions in neurodegenerative disorders. Brain Res. Bull. 2001;54:405–411
  29. Sassa S. Why heme needs to be degraded to iron, biliverdin IXalpha, and carbon monoxide?. Antioxid. Redox Signal. 2004;6:819–824
  30. Sassa S, Nagai T. The role of heme in gene expression. Int. J. Hematol. 1996;63:167–178
  31. Schipper HM. Heme oxygenase-1: transducer of pathological brain iron sequestration under oxidative stress. Ann. N. Y. Acad. Sci. 2004;1012:84–93
  32. Schipper HM. Heme oxygenase expression in human central nervous system disorders. Free Radic. Biol. Med. 2004;37:1995–2011
  33. Song W, Su H, Song S, Paudel HK, Schipper HM. Over-expression of heme oxygenase-1 promotes oxidative mitochondrial damage in rat astroglia. J. Cell. Physiol. 2006;206:655–663
  34. Suzuki S, Kiyosue K, Hazama S, Ogura A, Kashihara M, Hara T, et al. Brain-derived neurotrophic factor regulates cholesterol metabolism for synapse development. J. Neurosci. 2007;27:6417–6427
  35. Takahashi S, Takahashi T, Mizobuchi S, Matsumi M, Yokoyama M, Morita K, et al. CYP2E1 overexpression up-regulates both non-specific delta-aminolevulinate synthase and heme oxygenase-1 in the human hepatoma cell line HLE/2E1. Int. J. Mol. Med. 2003;11:57–62
  36. Taketani S, Immenschuh S, Go S, Sinclair PR, Stockert RJ, Liem HH, et al. Hemopexin from four species inhibits the association of heme with cultured hepatoma cells or primary rat hepatocytes exhibiting a small number of species specific hemopexin receptors. Hepatology. 1998;27:808–814
  37. Tringali G, Vairano M, Dello Russo C, Preziosi P, Navarra P. Lovastatin and mevastatin reduce basal and cytokine-stimulated production of prostaglandins from rat microglial cells in vitro: evidence for a mechanism unrelated to the inhibition of hydroxy-methyl-glutaryl CoA reductase. Neurosci. Lett. 2004;354:107–110
  38. Tschudy DP, Hess RA, Frykholm BC. Inhibition of delta-aminolevulinic acid dehydrase by 4,6-dioxoheptanoic acid. J. Biol. Chem. 1981;256:9915–9923
  39. Tsuji A, Saheki A, Tamai I, Terasaki T. Transport mechanism of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors at the blood-brain barrier. J. Pharmacol. Exp. Ther. 1993;267:1085–1090
  40. Tutois S, Montagutelli X, Da Silva V, Jouault H, Rouyer-Fessard P, Leroy-Viard K, et al. Erythropoietic protoporphyria in the house mouse. A recessive inherited ferrochelatase deficiency with anemia, photosensitivity, and liver disease. J. Clin. Invest. 1991;88:1730–1736
  41. Vaughan CJ. Prevention of stroke and dementia with statins: Effects beyond lipid lowering. Am. J. Cardiol. 2003;91:23B–29B
  42. Wagstaff LR, Mitton MW, Arvik BM, Doraiswamy PM. Statin-associated memory loss: analysis of 60 case reports and review of the literature. Pharmacotherapy. 2003;23:871–880
  43. Wang J, Dore S. Heme oxygenase-1 exacerbates early brain injury after intracerebral haemorrhage. Brain. 2007;130:1643–1652
  44. Wierzbicki AS, Poston R, Ferro A. The lipid and non-lipid effects of statins. Pharmacol. Ther. 2003;99:95–112
  45. Wilks A, Ortiz de Montellano PR, Sun J, Loehr TM. Heme oxygenase (HO-1): His-132 stabilizes a distal water ligand and assists catalysis. Biochemistry. 1996;35:930–936
  46. Yin L, Wu N, Curtin JC, Qatanani M, Szwergold NR, Reid RA, et al. Rev-erbalpha, a heme sensor that coordinates metabolic and circadian pathways. Science. 2007;318:1786–1789
  47. Zacco A, Togo J, Spence K, Ellis A, Lloyd D, Furlong S, et al. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors protect cortical neurons from excitotoxicity. J. Neurosci. 2003;23:11104–11111

PII: S0197-4580(08)00329-1

doi: 10.1016/j.neurobiolaging.2008.09.004

Neurobiology of Aging
Volume 31, Issue 9 , Pages 1543-1553 , September 2010

Article Tools

* Image Usage & Resolution